Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SECUKINUMAB Cause Vitamin d deficiency? 92 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 92 reports of Vitamin d deficiency have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.

92
Reports of Vitamin d deficiency with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
2
Deaths
20
Hospitalizations

How Dangerous Is Vitamin d deficiency From SECUKINUMAB?

Of the 92 reports, 2 (2.2%) resulted in death, 20 (21.7%) required hospitalization, and 2 (2.2%) were considered life-threatening.

Is Vitamin d deficiency Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 92 reports have been filed with the FAERS database.

What Other Side Effects Does SECUKINUMAB Cause?

Drug ineffective (27,434) Psoriasis (21,976) Pain (15,244) Arthralgia (13,769) Fatigue (9,406) Psoriatic arthropathy (8,900) Pruritus (8,755) Malaise (8,570) Rash (8,023) Condition aggravated (7,536)

What Other Drugs Cause Vitamin d deficiency?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,029) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (639) ALENDRONATE (500) TENOFOVIR DISOPROXIL (467) ADALIMUMAB (426) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (392) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (367) METHOTREXATE (241) ETANERCEPT (226) FINGOLIMOD (224)

Which SECUKINUMAB Alternatives Have Lower Vitamin d deficiency Risk?

SECUKINUMAB vs SELADELPAR LYSINE SECUKINUMAB vs SELEGILINE SECUKINUMAB vs SELENIUM SECUKINUMAB vs SELENIUM SULFIDE SECUKINUMAB vs SELEXIPAG

Related Pages

SECUKINUMAB Full Profile All Vitamin d deficiency Reports All Drugs Causing Vitamin d deficiency SECUKINUMAB Demographics